CD63+ neutrophil subsets

There is 1 paper on CD63+ neutrophil subsets in aging research: none in people yet, 1 in cells.

Biomarker

1 paper studies it1 finding

1 new paper in 30 daysSee all 1 papers on CD63+ neutrophil subsets

  • Cells1

Interventions

1

Arginyl-a-aspartyl-lysyl-valyl-tyrosyl-arginine

downin human cells1

1 study
  1. Arginyl-a-aspartyl-lysyl-valyl-tyrosyl-arginine decreases CD63+ neutrophil subsets in human cells (chronic obstructive pulmonary disease).

    “After incubation with arginyl-a-aspartyl-lysyl-valyl-tyrosyl-arginine, an increase in the neutrophil granulocyte subset CD63-CD16brightCD62LbrightCD11bbright was observed, while the CD63+CD16brightCD62LbrightCD11bbright and CD63+CD16brightCD62LdimCD11bbright neutrophil subsets were reduced.”

    Cellschronic obstructive pulmonary diseaseperipheral blood neutrophilic granulocytes

    In vitro effects of synthetic immunotropic hexapeptides on CD63-CD16+CD62L+CD11b+ and CD63+CD16+CD62L+CD11b+ neutrophilic granulocytes in elderly and senile patients with chronic obstructive pulmonary disease

    Russian Journal of Immunology

More on Arginyl-a-aspartyl-lysyl-valyl-tyrosyl-arginine

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 1Nov 2026: 01 paper in 12 months